Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

DrugCheck Ketamine Dip Test 31317-3P PRO-EU-SWE Recalled by Express Diagnostics Int'l., Inc. Due to This recall has been initiated due to potential...

Date: November 21, 2014
Company: Express Diagnostics Int'l., Inc.
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Express Diagnostics Int'l., Inc. directly.

Affected Products

DrugCheck Ketamine Dip Test 31317-3P PRO-EU-SWE, 31226-3-CA-GML, 30842 TR, 30108C, 30108C CAN, 30108C EU, and 30108C INT. This assay provides only a preliminary analytical test result.

Quantity: 5,050

Why Was This Recalled?

This recall has been initiated due to potential false positives results when using the test to screen for Ketamine. Use of this product may give incorrect screening results.

Where Was This Sold?

This product was distributed to 4 states: CA, MN, NY, SC

Affected (4 states)Not affected

About Express Diagnostics Int'l., Inc.

Express Diagnostics Int'l., Inc. has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report